Clinical Trials
In 8 weeks
25%
Average wrinkle volume reduction*
*Observed in a placebo-controlled clinical trial conducted with VERISOL®.
In 8 weeks
26–29%
Increased skin moisture levels*
*A significant increase has been reported compared to placebo.
In 8 weeks
9%
Increased skin elasticity*
*Reported based on objective instrument measurements.
Below you will find PDF copies of clinical studies on VERISOL® bioactive collagen peptides. The documents are presented in their original format.
VERISOL® (GELITA AG, Germany) – Summary of Clinical Findings
Double-blind, placebo-controlled clinical studies on VERISOL® bioactive collagen peptides have shown significant effects on skin appearance and dermal matrix synthesis.
Skin Wrinkles
- In week 4, there was an average reduction of 9% in the volume of wrinkles around the eyes.
- Average 25% decrease in week 8.
- Up to 51% reduction in individual cases.
Skin Elasticity
- 6% increase in 4 weeks
- 9% increase in 8 weeks
Skin Moisture Level
- 18% increase in 4 weeks
- 26–29% increase in 8 weeks
Effect on Hair Thickness
- Hair thickness increased by +1.93 µm.
- A decrease of -0.99 µm in the placebo group.
- 31% increase in hair follicle cell proliferation.
The data on this page has been compiled from relevant scientific studies. Dietary supplements are not intended for the prevention or treatment of diseases.